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RING1B, a Polycomb Group (PcG) protein, binds
methylated chromatin through its association with
another PcG protein called Polycomb (Pc). However,
RING1B can associate with nonmethylated chro-
matin suggesting an alternate mechanism for
RING1B interactionwith chromatin. Here, we demon-
strate that two proteins with little sequence identity
between them, the Pc cbox domain and RYBP,
bind the same surface on the C-terminal domain of
RING1B (C-RING1B). Pc cbox and RYBP each fold
into a nearly identical, intermolecular beta sheet
with C-RING1B and a loop structure which are
completely different in the two proteins. Both the
beta sheet and loop are required for stable binding
and transcription repression. Further, a mutation en-
gineered to disrupt binding on the Drosophila
dRING1 protein prevents chromatin association
and PcG function in vivo. These results suggest
that PcG targeting to different chromatin locations
relies, in part, on binding partners of C-RING1B that
are diverse in sequence and structure.
INTRODUCTION
ThePolycombGroup (PcG)of genesilencers arechromatin-asso-
ciatedmultiproteincomplexes thatmaintain thegenomicprogram
of cells (Schwartz and Pirrotta, 2008). In stem cells, PcG
complexes bind to hundreds of genomic loci, where they repress
genes that promote differentiation (Boyer et al., 2006; Lee et al.,
2006). A fundamental question regarding PcG function is how
these complexes bind specifically to so many sites. Such target-
ing would appear to require highly specific and elaborate regula-
tory mechanisms since it is ultimately responsible for maintaining
the intricate balance between pluripotency and differentiation.
Several of the multiprotein PcG complexes have been isolated
and shown to have distinct repressive functions. Polycomb966 Structure 18, 966–975, August 11, 2010 ª2010 Elsevier Ltd All rirepression complex 1 (PRC1) is composed of four core compo-
nents: Polycomb (Pc), RING1A or RING1B (dRING1 or Sex
combs extra in Drosophila), Bmi-1 or Mel-18 (Posterior sex
combs, Psc, in Drosophila), and Polyhomeotic (Ph) (Francis
et al., 2001; Shao et al., 1999). In vitro experiments suggest
that PRC1 may mediate repression through chromatin compac-
tion and the inhibition of chromatin remodeling enzymes (Francis
et al., 2001, 2004; Shao et al., 1999). Alternatively, the ligation of
ubiquitin to lysine 119 of histone H2A (Wang et al., 2004a), which
is catalyzed by a heterodimer formed by the RING finger
domains of RING1B and Bmi-1 (Buchwald et al., 2006; Li et al.,
2006), maymaintain RNA polymerase II in an inactive, but poised
position at repressed genes (Stock et al., 2007). A potential way
for these two distinct repressive mechanisms of PRC1 could
exist was recently suggested by the identification of a PRC1-
like complex in Drosophila called dRAF (Lagarou et al., 2008).
The dRAF complex is distinct from PRC1 but still contains two
of the PRC1core components (Psc and dRING1) and is a compe-
tent Ub ligase. Thus, it may be possible for the PRC1-like dRAF
complex to function as a ubiquitin E3 ligase while PRC1 may
function to create higher order repressive chromatin structures.
What is largely unresolvedwith regards to PcG function are the
precise mechanisms of targeting PcG complexes to hundreds of
locations within genomes. PcG complexes bind to cis-regulatory
DNA elements called Polycomb response elements (PREs). In
Drosophila, a PcG protein called Pleiohomeotic (Pho), the only
PcG protein capable of binding a specific DNA sequence, plays
a key role in directing PRC1 to the PREs (Wang et al., 2004b).
Pho can cooperate with PRC1 to bind PREs that are depleted
of histones forming a repressive structure whereby the DNA is
wrapped around the Pho/PRC1 complex (Mohd-Sarip et al.,
2005, 2006). Pho is also a component of a distinct PcG complex
called PhoRCwhich includes the PcG protein dSfmbt (Klymenko
et al., 2006). Themethylated histone binding ability of the dSfmbt
MBT domain (Grimm et al., 2009; Klymenko et al., 2006) may
allow PhoRC to utilize the combination of the DNA binding ability
of Pho and methylated histone binding of dSfmbt to bind specif-
ically to hundreds of sites within the Drosophila genome (Oktaba
et al., 2008). While Pho is clearly important for PRE PcG target-
ing, a PRE prediction algorithm using the DNA binding sequence
of Pho and other PcG-associated proteins (Ringrose et al., 2003)ghts reserved
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Pc and RYBP Share a Single Binding Site on RING1Bfailed to detect most PcG binding sites identified from several
Drosophila genome-wide studies (Negre et al., 2006; Schwartz
et al., 2006; Tolhuis et al., 2006). Predicting PREs in vertebrate
genomes have proved to be a challenging task and the identifi-
cation of twomammalian PREs have only been recently reported
(Sing et al., 2009; Woo et al., 2010). Like the PREs in Drosophila,
the mammalian PREs contain DNA sequences that are recog-
nized by the homolog of Pho, Yin Yang 1 (YY1).
The vertebrate PRC1 component that likely plays a key role in
directing PRC1 to the YY1 binding sites is RING1A or RING1B.
The C-terminal domain of RING1A or RING1B (C-RING1A or
C-RING1B) binds to the C-terminal region of an adaptor protein
calledRYBP (RING1YY1binding protein) while a nonoverlapping
N-terminal portion of RYBP associates with YY1 (Garcia et al.,
1999). This type of protein-protein interactionwould allow target-
ing of PRC1 to specific DNA sequences in the mammalian
genome. The important role played by RYBP in PcG function is
reflected in its requirement for repression mediated through
the mammalian PRE (Woo et al., 2010).
RING1B also plays a role in an alternative mechanism of
targeting PRC1 to chromatin. The posttranslational trimethyla-
tion of histone H3 at lysine 27 (H3K27Me3) is important in
PRC1 targeting. The N-terminal chromo domain of Pc binds
H3K27Me3 (Cao et al., 2002; Fischle et al., 2003; Min et al.,
2003), providing one avenue by which PRC1 can be targeted
to chromatin. The C-terminal cbox domain of Pc directly associ-
ates with C-RING1B (Schoorlemmer et al., 1997), facilitating
assembly of PRC1 at the histone posttranslational modification.
It should be noted that the chromo domain from other vertebrate
Pc orthologs are capable of binding different histone methyla-
tions besides H3K27Me3 (Bernstein et al., 2006). For example,
cbx7 can bind both H3K9Me3 as well as H3K27Me3. Because
of this and perhaps of alternative targeting mechanisms for
PRC1, there are many instances where RING1B is bound to
chromatin at locations other than H3K27Me3. There are several
examples of this phenomenon. (1) In preimplantation embryos,
paternal heterochromatin that lacks H3K27Me3 can still bind
maternal RING1B and other PRC1 components (Puschendorf
et al., 2008). (2) In embryonic stem cells that are deficient in
the enzyme that methylates H3K27 and thus lack H3K27Me3,
RING1B can still bind to the X chromosome (Schoeftner et al.,
2006). (3) In mouse embryonic stem cells, RING1B was found
to bind to the promoter region of 244 genes (of the 1219 total
genes that exhibit RING1B binding) where the H3K27Me3 was
not detected (Boyer et al., 2006). While it is possible that RING1B
is present at these sites but not detected, alternative recruitment
mechanisms may also be in play. Moreover, the Drosophila
ortholog dRING1 has been shown to localize to sites on polytene
chromosomes that are independent of other PRC1 components
(Gorfinkiel et al., 2004).
C-RING1B was predicted to have (Sanchez-Pulido et al.,
2008) and confirmed to possess a ubiquitin fold (Bezsonova
et al., 2009) but how it is capable of having multiple binding
partners remains unknown. Here, we provide evidence suggest-
ing how RING1B, and by extension, PRC1, can be specifically
targeted to different sites in the genome. We show that two
different binding partners to C-RING1B, the Pc cbox domain
and RYBP, can be very different in their sequence and bind
with different conformations to RING1B. Yet, despite theseStructure 18, 96differences, these proteins bind to the same binding site on
RING1B. This finding has important implications for the types
of multiprotein PRC1-like complexes that can form in vivo and
how they might be targeted to chromatin.
RESULTS
C-RING1B cbx7 cbox Structure
In order to better understand the protein-protein interactions of
C-RING1B, we first determined the structure of C-RING1B
bound to a Pc cbox domain. Of the five vertebrate Pc orthologs,
we chose the cbox domain from cbx7 for crystallization because
of its strong affinity for C-RING1B (Kd = 9.2 nM) (Wang et al.,
2008). To facilitate crystallization, we used C-RING1B and
cbx7 cbox residues (223–333 and 219–248, respectively) which
showed the least amount of conformational flexibility when in
complex with each other based on NMR relaxation measure-
ments (Figures 1A and 1B; see Figure S1 available online).
We determined the crystal structure of the C-RING1B/cbx7
219–248 complex and refined it to 1.7 A˚ resolution (Fig-
ures 1C–1E; Table S1). In the crystal, there are two C-RING1B/
cbx7 cbox complexes in the asymmetric unit associated via
the interaction between each of their long central helices. Our
mutagenesis data (Demeler et al., 2010) as well as the structure
of C-RING1B alone (Bezsonova et al., 2009) indicate that this
interaction is the homodimerization interface of C-RING1B
when C-RING1B is devoid of either the Pc cbox or RYBP.
Because this interaction occurs only in the absence of a binding
partner (Czypionka et al., 2007; Wang et al., 2008), the two
C-RING1B molecules in the asymmetric unit are likely the result
of the high concentration of protein required for crystallization
and not reflective of what occurs inside cells. Our analysis of
the structure is thus focused on a single heterodimer unit. The
C-RING1B structure is composed of an extensive beta sheet
region and a long central helix that extends from residue Val
256 to Glu 277. Residues 219–238 of the cbx7 cbox domain
form an antiparallel beta sheet which makes an extended, inter-
molecular beta sheet with C-RING1B. The combined beta sheet
structure packs against the C-RING1B central helix. In the cbox
beta sheet (Figure 1D), the side-chain aromatic ring of cbx7 Phe
234 is most notable as it stacks against the side-chain aromatic
ring of RING1B Tyr 262. Additionally, cbx7 beta sheet residues
Thr 223, Ile 225, Ala 227, and Val 232 are clustered around Phe
234, packing against a hydrophobic pocket formed by RING1B
residues Ile 248, Thr 250, Ala 254, His 258, Leu 259, Tyr 262,
and Val 265. In addition to the backbone hydrogen bonds
between C-RING1B and cbx7 that comprise the intermolecular
beta sheet structure, there is a side-chain mediated polar inter-
action between cbx7 Glu 236 and RING1B residues Arg 246
and Tyr 262. Furthermore, cbx7 residues 239–248 form a loop
structure that contacts C-RING1B (Figure 1E). In the cbox loop
region, two consecutive cbx7 Phe residues, 243 and 244, pack
into a hydrophobic pocket formed by RING1B residues Val
229, Tyr 247, and Pro 324. The side chains of RING1B residues
Lys 249 and Glu 227 are in an extended conformation and are
hydrogen bonded to the backbone atoms of the cbox loop
residues. These extended conformations allow the methylene
groups on these residues to help form the binding pocket for
Phe 243 and 244. The guanidinium group of cbx7 Arg 2476–975, August 11, 2010 ª2010 Elsevier Ltd All rights reserved 967
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Figure 1. C-RING1B/cbx7 cbox Structure
(A) ClustalW sequence alignment of the cbox
domains from all five human and Drosophila Pc
proteins and the region of the human RYBP
sequence known to associate with C-RING1B
(Garcia et al., 1999). The underlined sequences
represent the residues used in the crystallization.
(B) The C-terminal domains from human RING1A,
RING1B, and Drosophila RING1 proteins.
Secondary structures are indicated as arrows
(beta sheet) and cylinders (helix). Residues that
mediate hydrophobic and polar interactions are
dark and light shaded, respectively.
(C) Structure of the C-RING1B cbx7 cbox
complex. The RING1B is blue, cbx7 is yellow.
Termini are labeled. The dotted line indicates
RING1B residues 285 and 288 which could not
be modeled because of weak density.
(D and E) A closeup view of the (D) beta sheet and
(E) the loop interactions. Cbx7 residues 219–224
are deleted in (D) for clarity. C-RING1B residues
are labeled in blue, cbx7 residues are labeled in
black.
Structure
Pc and RYBP Share a Single Binding Site on RING1Bforms a salt bridge interaction with the RING1B Glu 227 side
chain while also hydrogen bonding to the carboxamide group
of RING1B Gln 322.
Both the cbox beta Sheet and Loop Are Required
for Binding C-RING1B and for Repression
We next tested whether both the beta sheet and the loop struc-
ture of the cbox domain are necessary for binding. We intro-
duced mutations into C-RING1B that alter either the beta sheet
binding site (Tyr262Ala and His258Ala) or the cbox loop binding
site (Val227Ala and Tyr247Ala) and then tested each of these
mutant proteins for binding to the cbx7 cbox domain using a
native gel binding assay (Figure 2A). These mutations are of
surface residues and do not disrupt the tertiary fold (Figure S2).
The mutant C-RING1B proteins showed diminished ability to
bind cbx7 cbox, as indicated by the significant amounts of968 Structure 18, 966–975, August 11, 2010 ª2010 Elsevier Ltd All rights reservedresidual unbound cbx7 cbox that was
observed for all the mutants except for
Val229Ala (compare the bands for faster
migrating unbound cbx7 cbox in Fig-
ure 2A lane 7 for wild-type to the corre-
sponding bands in lanes 8–11). We also
performed the complementary experi-
ment of testing the binding of cbx7 cbox
proteins mutated at the beta sheet and
loop regions. When cbx7 cbox was
mutated in the beta sheet, Phe234Asp,
there was no binding to C-RING1B (Fig-
ure 2B, lane 7). The cbx7 loop mutation
Phe244Asp was found to be capable of
associating with C-RING1B, but with
reduced affinity, as indicated by the pres-
ence of a substantial quantity of unbound
cbx7 protein (Figure 2B, compare the
bands for cbx7 in lanes 6 and 8). We
further tested the role of the cbox loopinteraction with C-RING1B by deleting cbx7 loop residues
altogether. Deleting the loop of cbx7 cbox completely disrupted
binding (Figure 2B, lane 9). The results of these mutagenesis
studies are consistent with our NMR data which showed
that Pc cbox domains were unstructured in the absence of
C-RING1B (Wang et al., 2008). NMR conformational dynamics
measurements revealed that upon binding C-RING1B, both the
beta sheet and the loop structure of the cbx7 cbox domain
become ordered (Figure S1A).
Previously published transcription assays using recombinant
Pc proteins targeted to reporter genes had shown that the
cbox domain is required for repression (Bardos et al., 2000;
Bunker and Kingston, 1994; Muller, 1995). We wondered
whether specific, structure-guided point mutations within the
cbox domain designed to disrupt binding to C-RING1B would
hinder the ability of Pc to repress transcription. To this end,
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B Figure 2. Beta Sheet and Loop Interactions
Are Both Required for Binding and
Repression
(A) Native gel binding assay testing C-RING1B
wild-type and mutant proteins binding to maltose
binding protein (MBP) fused cbx7 cbox. Arrows
indicate the 1:1 complex between the C-RING1B
protein and its binding partner.
(B) Binding reactions using MBP-cbx7 cbox
mutants. The MBP-cbx7 loop deletion termi-
nates at cbx7 residue 240. The C-RING1B
Tyr262Ala mutant likely disrupts the homodimeri-
zation of C-RING1B which would alter its
mobility in a native gel compared to the other
C-RING1B proteins.
(C) Transcription assay. Five repeats of the
zif268 binding site are placed upstream of the
metallothionine promoter (MTp). The zinc finger
DNA binding domain of zif268 fused to dPc
allows targeting to the MTp. Binding of endoge-
nous dRING1 and other endogenous compo-
nents to the MTp can lead to repression.
(D) Transcription assay results. Error bars are the
standard deviations from three independent
transfections. (inset) Anti-FLAG immunoblot of
the exogenous dPc proteins expressed in cells.
Equivalent lysate volumes used in the transcription
assay were used for the immunoblot. Unfortu-
nately, a similar experiment using dRING1 could
not be performed because overexpression of
dRING1 alone and one that is targeted to the
MTp resulted in similar levels of luciferase activity.
Structure
Pc and RYBP Share a Single Binding Site on RING1Bwe used a transcription assay carried out in Drosophila S2 cells
using the full-length Drosophila Pc (dPc) protein (Figure 2C).
Using this assay, we found that the dPc that was targeted to
an exogenous metallothionine promoter (MTp) was able to
repress transcription of the luciferase reporter gene. In contrast,
there was elevated luciferase activity with a dPc that was
similarly expressed but not targeted to the MTp (Figure 2D).
We also introduced mutations into dPc cbox that are equivalent
to the cbx7 cbox mutations that hinder cbx7 cbox binding to
RING1B (discussed above). The cbox beta sheet mutation
Ile367Ala (equivalent to cbx7 Phe 234) and the loop residue
mutant Phe377Ala (Phe 244 in cbx7) were both found to be
incapable of repressing the expression of the reporter gene as
compared to wild-type. Taking all of the in vitro and in vivo
results together, we conclude that both the cbox beta sheet
and loop structures are required to form a stable complex
with C-RING1B, which in turn is required for full transcription
repression.Structure 18, 966–975, August 11, 2010RYBP/YAF2 Binding to C-RING1B
Is Similar to the C-RING1B/Pc
cbox Interaction
Evidence indicates a strong likelihood
that RING1B targeting is dependent on
the identity of the binding partner(s) of
C-RING1B. For example, multiprotein
complexes that include RING1B and
RYBP (or its homolog YAF2) also contain
proteins like E2F6, E2F2, E2F3, hGABPb,and YY1, all of which have DNA binding domains (Garcia et al.,
1999; Ogawa et al., 2002; Sawa et al., 2002; Schlisio et al., 2002;
Trimarchi et al., 2001; Zheng et al., 2001). If the binding target
of RING1B is a specific DNA sequence and not methylated
chromatin, then C-RING1B would have to bind RYBP with 1:1
stoichiometry while not allowing C-RING1B to bind the Pc
cbox domains. If the stoichiometry of the interactions is greater
than 1:1 utilizing multiple binding surfaces on C-RING1B, then
a single RING1B protein could simultaneously bind to two
different sites. Since there is little sequence similarity between
RYBP and the Pc cbox domains (Figure 1A), it is difficult to
predict how RYBP binds to C-RING1B. We performed a series
of experiments to investigate the C-RING1B/RYBP interaction
and compared the results to those for the C-RING1B/Pc cbox
complex. Using velocity sedimentation, we assessed the
stoichiometry of the complex between C-RING1B and RYBP
residues 145–198, a previously identified C-terminal region of
RYBP that is capable of binding C-RING1B (Garcia et al.,ª2010 Elsevier Ltd All rights reserved 969
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Structure
(A) The van Holde-Weischet integral distribution
plot of the C-RING1B/RYBP 145–198 complex at
two different concentrations (D: 16 mM; d: 56 mM).
(B) Native gel binding assay between C-RING1B
(wild-type and mutant proteins) and MBP-YAF2
103–150.
(C) Table of the equilibrium dissociation constants
between the indicated RYBP construct and
C-RING1B measured using SPR (Figure S3).
(D) 1D 1H NMR of RYBP 145–179.
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Pc and RYBP Share a Single Binding Site on RING1B1999) (Figure 3A). The sedimentation velocity van Holde-
Weischet distribution plot of the C-RING1B/RYBP 145–198
complex revealed the presence of a homogeneous species
with an S-value of 2. Using a genetic algorithm (Brookes and
Demeler, 2007) and a nonlinear least-squares finite element
analysis (Demeler and Saber, 1998), we determined the molec-
ular weight of the complex to be 21.6 kDa, matching the
calculated molecular weight for a 1:1 stoichiometry. In order
to determine if the same C-RING1B surface binds both the Pc
cbox domain and RYBP, we used a native gel binding assay
and tested the association between the structure-guided
C-RING1B mutants and YAF2, a close homolog to RYBP (Fig-
ure 3B). (We used YAF2 in lieu of RYBP because the migration
of C-RING1B/RYBP complex in the native gel could not be
distinguished from the individual components.) Our finding
that the C-RING1B mutants that hinder Pc cbox binding also
disrupted YAF2 binding suggested that the same surface is
used to bind both proteins. Next, we determined the minimum
region within RYBP required to bind C-RING1B. We made
a series of RYBP constructs (145–184, 145–179, 145–175,
149–198) and measured their affinity to C-RING1B using surface
plasmon resonance (SPR) (Figure 3C; Figure S3A–S3E). The
equilibrium dissociation constants (Kd) for C-RING1B binding
to RYBP 145–198 and RYBP 145–179 were similar (100 and
90 nM, respectively) while RYBP constructs shorter than
145–179 exhibited significantly lower affinity. This suggests
that the 35 residues in RYBP 145–179 represent the minimum970 Structure 18, 966–975, August 11, 2010 ª2010 Elsevier Ltd All rights reservedregion required to bind C-RING1B. Like
the Pc cbox domains which are unfolded
in the absence of C-RING1B (Wang et al.,
2008), RYBP 145–179 shows no upfield
or downfield shifts in its 1D NMR spec-
trum, indicating the absence of a tertiary
fold (Figure 3D). This is consistent with
previous observations from analysis of
a larger region of RYBP (Neira et al.,
2009). Also similar to the Pc cbox
domains, the 2D HSQC spectrum of
C-RING1B shows a greater dispersion
of chemical shifts in the presence of
RYBP 145–179 compared to C-RING1B
alone (Figure S3B). Conformational
tightening within C-RING1B when incomplex with RYBP or the Pc cbox domain would be expected
to result in a more dispersed spectrum.
RYBP Shares the Same Binding Site on C-RING1B
as the cbx7 cbox Domain
To view the binding mode between RYBP and C-RING1B, we
determined the 1.7 A˚ crystal structure of C-RING1B bound to
RYBP 145–179 (Figure 4). The structure revealed that despite
significant differences in their sequences (Figure 1A), RYBP
145–179 binds to the same hydrophobic patches on the surface
of C-RING1B as the cbx7 cbox domain. RYBP residues
158–172 folds into an antiparallel beta sheet that is nearly
identical to the beta sheet formed by the cbx7 cbox domain
(Figure 4A). Similar to cbx7 cbox, RYBP also has a loop struc-
ture which binds to the same C-RING1B surface that the cbx7
loop structure binds to. However, there are significant differ-
ences between the loop structures from cbx7 cbox and
RYBP. For example, while the cbx7 loop is formed by residues
that are C-terminal to the cbx7 cbox beta sheet, it is residues
that are N-terminal to the RYBP beta sheet that form the
RYBP loop. Because of this, it is not surprising that the RYBP
backbone conformation is completely different from that of
the cbx7 cbox loop (Figures 4B and 4C). A notable way that
RYBP can adopt a conformation differently than the Pc cbox
is demonstrated by RYBP residues 173–175. In the ClustalW
alignment (Figure 1A), RYBP residues 173–175 (FKE) align
with cbx7 residue 234–236 (FRE). Cbx7 Phe 234 is part of the
Figure 4. C-RING1B/RYBP Structure
(A and B) Close up of the (A) beta sheet interaction and (B)
the loop interaction. RING1B and RYBP are drawn in blue
and magenta, respectively.
(C) Overlay of the C-RING1B/RYBP 145–179 on the
C-RING1B/cbx7 cbox. The C-RING1B is shown as a
surface representation, cbx7 cbox is colored yellow and
RYBP is in magenta. Key hydrophobic residues that share
the same C-RING1B loop binding surface are highlighted
on both cbx7 and RYBP. RYBP residues are labeled in
magenta and cbx7 residues are labeled in black.
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Pc and RYBP Share a Single Binding Site on RING1Bintermolecular beta sheet and participates in a key hydrophobic
stacking interaction with C-RING1B Tyr 262, while cbx7 Glu 236
forms a key salt bridge interaction (Figure 1D). RYBP Phe 173
also plays a key role in binding C-RING1B, but rather than
participating in a stacking interaction with C-RING1B Tyr 262
in the beta sheet region as cbx7 Phe 234 does, RYBP Phe
173 binds to the loop binding surface on C-RING1B while Glu
175 does not contact C-RING1B at all (Figure 4B). These results
demonstrate the conformational diversity that is present among
C-RING1B binding partners that are capable of using a single,
shared binding surface on C-RING1B. The consequence of
the shared binding site would result in C-RING1B having a single
binding partner at one time.
Mutation of the Shared Binding Site of C-RING1B
Disrupts Chromosome Localization
We next determined the consequences of disrupting the shared
binding site of RING1B in vivo. To do so, we performed experi-
ments using transgenic Drosophila and introduced a mutation
to the Drosophila RING1B ortholog, dRING1. Tyr 370 of dRING1
is equivalent to Tyr 262 of human RING1B; as discussed above,
Tyr 262 is a key residue that is required for stable complex
formation with the Pc cbox domain and RYBP (Figures 1D, 2A,
2B, and 4A). For this experiment, we expressed both wild-type
and a Tyr370Ala mutant form of FLAG epitope-tagged dRING1
in the posterior compartment of the wing disc (Figure S5).Structure 18, 966–975, August 11Whereas overexpression of wild-type dRING1
failed to affect development, expression of
dRING1Y370A was pupal lethal. A few escapers
were observed, all of which exhibited defects
in thorax closure (Figure 5A). Interestingly, a
similar thorax closure phenotype was previ-
ously observed in Drosophila Pc/pnrGal4 trans-
heterozygous mutants (Pena-Rangel et al.,
2002). Given that we designed the mutant with
the intent of disrupting the binding function of
dRING1, it was perhaps not surprising that the
Tyr370Ala mutant functioned as a dominant
negative. When the dRING1 transgenes were
expressed in the salivary glands (Figure 5B),
the exogenous wild-type dRING1 showed a
banding pattern similar to that previously
observed for endogenous dRING1 (Gorfinkiel
et al., 2004). The ability to associate with
chromosomes was found to be severely com-promised for the Try370Ala dRING1 mutant, reflecting the key
targeting role played by C-dRING1.
DISCUSSION
We have shown that two C-RING1B binding partners that differ
in amino acid sequence and attain different conformations bind
to the same site on the surface of C-RING1B. Our finding has
important implications for PRC1 assembly and targeting. If
a PRC1 complex contains a single RING1B protein and a single
Pc protein, the likely target would be methylated chromatin.
RYBP binds C-RING1B with affinity (Kd = 90 nM) (Figure 3C;
Figure S3A) that is comparable to the binding affinity between
C-RING1B and the Pc cbox domains (Kd = 9.2–180 nM (Wang
et al., 2008). Because both RYBP and Pc cbox bind to the
same surface on C-RING1B, C-RING1B would be able to bind
only one of these proteins at a time. Therefore, rather than being
recruited to methylated chromatin when RING1B binds Pc, the
genomic location to which RING1B is targeted would depend
on the binding partner of RYBP that houses a DNA binding
domain.
It is worth noting that all PRC1-like complexes isolated from
vertebrate cells contain both RING1B and its close homolog
RING1A (Elderkin et al., 2007; Levine et al., 2002; Ogawa et al.,
2002; Sanchez et al., 2007; Wang et al., 2004a). How both
RING1A and RING1B can be present within a single PRC1 is, 2010 ª2010 Elsevier Ltd All rights reserved 971
Figure 5. Transgenic Drosophila melanogaster
(A) Expression of the mutant from the en-Gal4 driver results in a dominant
negative mutant phenotype. The images are of the dorsal side of the flies
showing a deficiency in thorax closure.
(B) Polytene chromosome from ey-Gal4; dRING1 transgenes were stainedwith
Rb-anti antibodies against the FLAG epitope to monitor transgene expression
(red) while DNA was counterstained with Hoescht dye (blue).
Structure
Pc and RYBP Share a Single Binding Site on RING1Bnot clear, though several protein-protein interaction domains
exist within PRC1 that may facilitate higher order stoichiome-
tries. Having both RING1A and RING1B in the same complex
could affect PRC1 targeting. If the C-terminal domain of RING1A
(C-RING1A) and C-RING1B bind different proteins, e.g., RYBP
and Pc, then the PRC1 complex could use a combinatorial
approach utilizing both a specific DNA sequence through RYBP
and also methylated chromatin that is recognized by the Pc
chromo domain, to determine the specific location for PRC1 to
bind to. Alternatively, two different genomic sites targeted by
the RING1A and RING1B binding partners could be used to
gather genomic elements that are separated by large intervening
sequences creating higher order chromatin structures that are
part of the coordinated repression mediated by PRC1.
In addition to the Pc cbox domain and RYBP/YAF2,
C-RING1B has also been shown to bindmethylated DNA binding
protein 1 (MBD1) (Sakamoto et al., 2007). Furthermore, a proteo-
mic analysis of RING1B-associated proteins has identified many
other binding partners (Sanchez et al., 2007). While the Psc or-
thologs (e.g., Bmi-1 and Mel-18) can form the heterodimeric
RING finger ubiquitin ligase with the N-terminal RING finger
domain of RING1B, it remains to be seen if any of the other
proteins identified in the proteomics study directly bind
C-RING1B. Our data indicate that regions as short as 30 resi-
dues can bind C-RING1B with strong affinity. Even among the
cbox domains of the different Pc orthologs, there is sufficient972 Structure 18, 966–975, August 11, 2010 ª2010 Elsevier Ltd All risequence diversity to predict that there will be alternative
structures of the cbox domains when they are bound to
C-RING1B. As seen in the sequence alignment of the Pc cbox
domains (Figure 1A), the cbox domain of cbx4 lacks residues
that are equivalent to cbx7 Phe 243 and Phe 244. These two
Phe residues in cbx7 are required for stable complex formation
(Figures 1E and 2B). They are also conserved in the Drosophila
Pc protein and are required for repression of transcription
(Figure 2D). Despite the absence of these critical residues,
cbx4 cbox is still capable of forming a stable complex with
C-RING1B (Wang et al., 2008). We have determined the struc-
ture of the cbox domain of cbx4 (also called Pc2) bound to
C-RING1B and found that cbx4 cbox utilizes the same binding
surface on C-RING1B as cbx7 cbox and RYBP (our unpublished
data). While the C-RING1B/cbx4 cbox structure further confirms
that sequence variations can be accommodated in an associa-
tionwith the same binding surface onC-RING1B, it also provides
insight into a possible reason why cbx4 evolved a different mode
of interaction with C-RING1B because cbx4 cboxmay be unique
in its ability to perform an oligomerization function. We are
currently investigating this possibility. The ability of C-RING1B
to bind to different proteins that have different functions, even
among the different Pc orthologs (Bernstein et al., 2006), may
allow RING1B to not only bind different sites but also to act as
repressors in a variety of pathways in different cell types. These
and other future studies with other C-RING1B binding partners
will be needed to help clarify the role of C-RING1B and provide
new insights into PcG assembly and function.EXPERIMENTAL PROCEDURES
Protein Preparations
All proteins used for this study are summarized in Table S1. C-RING1B
complexes used for NMR and X-ray crystallography were obtained by
coexpressing the C-RING1B construct in pET-30a and the hexahistidine-
tagged binding partner in pET-3c while maintaining both plasmids in the
presence of kanamycin and ampicillin, respectively. Proteins using the T7
promoter were expressed in BL21-Gold (DE3) (Stratagene) that had been
pretransformed with the pRARE plasmid (Novagen). MBP fusion proteins
were obtained by cloning the target gene into pBADM-41+ (EMBL) and were
expressed in ARI814 (Schatz et al., 1996) cells. One millimolar IPTG or 0.2%
arabinose was used to induce protein expression for the pET (T7 promoter)
and pBADM-41+ (araBAD promoter) clones, respectively. Typical protein
purification involved resuspending bacterial cells from a 1 liter culture in
10 ml of 50 mM Tris (pH 8.0), 100 mM NaCl, 25 mM imidazole (pH 7.5),
1 mM PMSF, and 5% glycerol, cell lysis by sonication, and extraction of the
protein using Ni affinity chromatography, followed by ion exchange chroma-
tography. The protein complexes used for crystallization were first purified
on a Ni affinity column, digested with TEV to remove the tag sequence on
the cbx7 219–248 and RYBP 145–179 constructs, followed by a second Ni
affinity chromatography where the nonbinding fractions were collected. The
complexes were further purified by ion exchange chromatography.
NMR Spectroscopy
All samples were labeled with 15N or with both 15N and 13C using minimal
media containing isotopically labeled 15N NH4Cl and
13C glucose. The purified
complexes were all prepared in 10 mM Na PO4 buffer (pH 6.0), 50 mM NaCl,
and 5% D2O. Spectra were recorded on a Bruker Av700 spectrometer
equipped with an actively shielded z-gradient triple resonance probe at
a temperature of 310 K. Spectra were processed with NMRPipe (Delaglio
et al., 1995) and analyzed with NMRView (Johnson and Blevins, 1994).
Backbone amide relaxation data sets were recorded using standard Bruker
pulse programs.ghts reserved
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C-RING1B/cbx7 219–248
The C-RING1B construct used for crystallization encompassed human
RING1B residues 223–333. Additionally, we mutated C-RING1B residue Asn
306 to Asp to prevent deamidation of the Asn residue. Asn 306 is not important
for cbox binding as mutating this residue to an Asp does not hinder cbox
binding (Figure S1B). The C-RING1B 223–333 N306D/cbx7 219–248 copuri-
fied complex was prepared to a concentration of 26 mg/ml and screened
for crystals using hanging drop vapor diffusion. See Supplemental Material
for all crystallization conditions. Data sets from the first native, iodide, and
Se-Met derivative crystals were collected on a Rigaku MicroMax 007HF
rotating anode X-ray generator equipped with R-AXIS HTC imaging plate
system (structure II), processed using HKL2000 (Otwinowski et al., 2003),
and input into SHARP (de La Fortelle and Bricogne 1997). SHELX-D (Sheldrick,
2008) identified the heavy atom positions from which phases were calculated.
Maps calculated following density modification (Collaborative Computational
Project, Number 4, 1994) allowed automatic model building of the initial chain
using ARP/wARP (Langer et al., 2008) and manual rebuilding was completed
using Coot (Emsley and Cowtan, 2004). The structure was refined using
PHENIX (Adams et al., 2002) against a second native data set collected to
1.7 A˚. A portion of the electron density map is shown in Figure S1C. Crystallo-
graphic statistics are shown in Table S1.
C-RING1B/RYBP 145–179
Crystals of both the native and Se-Met C-RING1B Asn306Asp/RYBP complex
were grown by hanging drop vapor diffusion set up at 16C using a protein
concentration of 20 mg/ml which was mixed with equal volume of well buffer.
Crystals were flash-cooled in liquid nitrogen prior to data collection. All data
were collected at the Advanced Light Source (ALS) Beamline 4.4.2 and
processed using d*TREK (Pflugrath, 1999). Fifteen selenium atom positions
were determined using SHELX (Sheldrick, 2008), and phases were calculated
and refined using autoSHARP (Vonrhein et al., 2007). Density modification,
model building, and refinement were carried out as described above.
Native Gel Electrophoresis Binding Assay
All binding reactions were carried out in 15 ml using equimolar concentrations
of C-RING1B and its binding partner. The protein concentration used for all the
reactions was 0.14 nmol. The binding reactions were equilibrated at room
temperature for at least 30 min in 10 mM Tris-HCl (pH 7.8), 50 mM NaCl,
and 5 mM b-mercaptoethanol prior to loading the samples onto a 10% native
polyacrylamide gel.
Transcription Assay
All exogenous Pc proteins were constitutively expressed using the actin 5c
promoter (plasmid was a kind gift from Dr. Albert J. Courey). The vector
containing the lacZ gene, also under control of the actin 5c promoter, was
a kind gift from Dr. Yuzuru Shiio. On day 1 of the assay, the plasmid bearing
the Pc gene, pGL2-Basic, lacZ plasmids (100, 7.5, and 7.5 ng, respectively)
were transiently transfected into 13 105Drosophila S2 cells in 100 ml of media
using Fugene HD transfection reagent (Roche Applied Science). On day 3, the
expression of the luciferase gene was induced by adding CuSO4 (100 mM).
Cells were harvested on day 4. LacZ activity was first measured using various
amounts of lysate in order to calculate volumes required to provide equivalent
amounts of lacZ activity for all of the individual transfections. Lysate volumes
calculated from this initial experiment were used in a second experiment
measuring both luciferase and lacZ activities. The Dual-Light Combine
Reporter Gene Assay System (Applied Biosystems) was used to measure
both enzyme activities using a microplate luminometer (Veritas). The data
are presented as the ratio of luciferase to b-galactosidase activity.
Analytical Ultracentrifugation
Protein samples were prepared in 10 mM Na PO4 buffer (pH 6.0) and 50 mM
NaCl. All sedimentation experiments were performed with a Beckman Optima
XL-I at the Center for Analytical Ultracentrifugation of Macromolecular
Assemblies (CAUMA) at the University of Texas Health Science Center at
San Antonio. The sedimentation experiments were performed at
55,000 rpm. The sedimentation velocity data were analyzed by UltraScan
version 9.9 (Demeler, 2005). Additional methods are described in the Supple-
mental Experimental Procedures.Structure 18, 96Transgenic Drosophila melanogaster
FLAG epitope-tagged dRING1wild-type and Tyr370Ala genes under control of
the Gal4 dependent UAS promoter were cloned into a vector required for
PhiC31 integration (Bischof et al., 2007). The DNA was injected into early
syncytial-stage blastoderm embryos (Rainbow Transgenics) that carries
both a source of the PhiC31 integrase on the X chromosome and attP
target site at chromosomal position 86Fa (yw; M{eGFP.vas-int.Dm}2A;M
{RFP.attP}86Fa). Successful transformants were selected on the basis of red
eye color associated with stable integration of thewhite gene intowhitemutant
background. Multiple independent transformant lines for each construct were
derived. To promote the expression of Gal4 in the posterior half of the devel-
oping wing imaginal disc and the salivary glands, the transgenic flies were
mated with the engrailed Gal4 (en-Gal4) and the eyeless (ey-Gal4) lines,
respectively. Detailed descriptions of Gal4 driver lines can be found at
http://flybase.org.
Polytene Chromosome Staining
Polytene chromosome squashes were prepared as described (Schwartz et al.,
2004). Recombinant proteins were labeled with a rabbit anti-DDDDK sera
(Abcam) and visualized with a goat anti-rabbit Alexa 568 secondary antibody
(Molecular Probes), whereas DNA was counterstained with Hoechst dye.
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The resonance assignments have been deposited to the Biological Magnetic
Resonance Bank (accession number 16229). Coordinates have been depos-
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3ISX (C-RING1B/RYBP 145–179).
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